An integrative analysis to identify driver genes in esophageal squamous cell carcinoma

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Sawada, Genta ^a,b   Niida, Atsushi ^c   Hirata, Hidenari ^a   Komatsu, Hisateru ^a,b   Uchi, Ryutaro ^a   Shimamura, Teppei ^c   Takahashi, Yusuke ^a,b   Kurashige, Junji ^a   Matsumura, Tae ^a,b   Ueo, Hiroki ^a   Takano, Yuki ^a   Ueda, Masami ^a,b   Sakimura, Shotaro ^a   Shinden, Yoshiaki ^a   Eguchi, Hidetoshi ^a   Sudo, Tomoya ^a   Sugimachi, Keishi ^a   Yamasaki, Makoto ^b   Tanaka, Fumiaki ^a   Tachimori, Yuji ^d   Kajiyama, Yoshiaki ^e   Natsugoe, Shoji ^f   Fujita, Hiromasa ^g   Tanaka, Yoichi ^h   Calin, George ⁱ   Miyano, Satoru ^c   Doki, Yuichiro ^b   Mori, Masaki ^b   Mimori, Koshi ^a   more..

^a KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

^g KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h SAITAMA CANCER CENTER   (Japan)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GROWTH FACTOR RECEPTOR BOUND PROTEIN 7; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SOX2; TRASTUZUMAB; GRB7 PROTEIN, HUMAN;

AGED; ARTICLE; CANCER PROGNOSIS; CARCINOGENESIS; CCND1 GENE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHROMOSOME 11Q; CHROMOSOME 17Q; CHROMOSOME 3Q; CHROMOSOME 7P; CONTROLLED STUDY; COPY NUMBER VARIATION; EGFR GENE; ERBB2 GENE; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; GROWTH FACTOR RECEPTOR BOUND PROTEIN 7 GENE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; RNA INTERFERENCE; SOX2 GENE; ALGORITHM; CHROMOSOME; CHROMOSOME ABERRATION; COHORT ANALYSIS; DNA MICROARRAY; ESOPHAGUS TUMOR; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; MALE; MIDDLE AGED; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; ULTRASTRUCTURE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES; COHORT STUDIES; DNA COPY NUMBER VARIATIONS; ESOPHAGEAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; GRB7 ADAPTOR PROTEIN; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RNA INTERFERENCE;

EID: 84948981557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139808     Document Type: Article

References (51)

1. Shimada H, Kitabayashi H, Nabeya Y, Okazumi S, Matsubara H, Funami Y, et al. Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery. 2003; 133(1):24-31. Epub 2003/02/04. doi: 10.1067/msy.2003.31 PMID: 12563234.
2. Enzinger PC, Mayer RJ. Esophageal cancer. The New England journal of medicine. 2003; 349 (23):2241-52. Epub 2003/12/06. doi: 10.1056/NEJMra035010 PMID: 14657432.
3. Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2007; 25(26):4110-7. Epub 2007/09/11. doi: 10.1200/jco.2007.12.0881 PMID: 17827461.
4. Nakamura T, Ota M, Narumiya K, Sato T, Ohki T, Yamamoto M, et al, Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol. 2008; 15(9):2451-7 Epub 2008/07/02. doi: 10.1245/s10434-008-0016-x PMID: 18592318.
5. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet (London, England). 2002; 359(9319):1727-33. Epub 2002/06/07. doi: 10.1016/s0140-6736(02)08651-8 PMID: 12049861.
6. Ando N, Iizuka T, Kakegawa T, Isono K, Watanabe H, Ide H, et al, A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. The Journal of thoracic and cardiovascular surgery. 1997; 114(2):205-9 Epub 1997/08/01. PMID: 9270637.
7. Solomon E, Borrow J, Goddard AD. Chromosome aberrations and cancer. Science (New York, NY). 1991; 254(5035):1153-60. Epub 1991/11/22. PMID: 1957167.
8. Sintupisut N, Liu PL, Yeang CH. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes. Nucleic acids research. 2013; 41(19):8803-21. Epub 2013/08/03. doi:10. 1093/nar/gkt656 PMID: 23907387; PubMed Central PMCID: PMCPmc3799430.
9. Reid JF, Gariboldi M, Sokolova V, Capobianco P, Lampis A, Perrone F, et al. Integrative approach for prioritizing cancer genes in sporadic colon cancer. Genes, chromosomes & cancer. 2009; 48(11):953-62 Epub 2009/08/13. doi: 10.1002/gcc.20697 PMID: 19672874.
10. Natrajan R, Weigelt B, Mackay A, Geyer FC, Grigoriadis A, Tan DS, et al. An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Breast cancer research and treatment. 2010; 121 (3):575-89. Epub 2009/08/19. doi: 10.1007/s10549-009-0501-3 PMID: 19688261.
11. Hu N, Wang C, Ng D, Clifford R, Yang HH, Tang ZZ, et al, Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China. Cancer research. 2009; 69(14):5908-17 Epub 2009/07/09. doi: 10.1158/0008-5472.can-08-4622 PMID: 19584285; PubMed Central PMCID: PMCPmc2734334.
12. Shi ZZ, Shang L, Jiang YY, Hao JJ, Zhang Y, Zhang TT, et al. Consistent and differential genetic aberrations between esophageal dysplasia and squamous cell carcinoma detected by array comparative genomic hybridization. Clinical cancer research: an official journal of the American Association for Cancer Research. 2013; 19(21):5867-78. Epub 2013/09/07. doi: 10.1158/1078-0432.ccr-12-3753 PMID: 24009147.
13. Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune K, Wands JR, et al. Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma. Cancer research. 1997; 57(1):28-31. Epub 1997/01/01. PMID: 8988034
14. Tanaka S, Mori M, Akiyoshi T, Tanaka Y, Mafune K, Wands JR, et al. A novel variant of human Grb7 is associated with invasive esophageal carcinoma. The Journal of clinical investigation. 1998; 102 (4):821-7. Epub 1998/08/26. doi: 10.1172/jci2921 PMID: 9710451; PubMed Central PMCID: PMCPmc508945.
15. Tanaka S, Sugimachi K, Kawaguchi H, Saeki H, Ohno S, Wands JR. Grb7 signal transduction protein mediates metastatic progression of esophageal carcinoma. Journal of cellular physiology. 2000; 183 (3):411-5. Epub 2000/05/08. doi: 10.1002/(sici)1097-4652(200006)183:3<411::aid-jcp14>3.0.co;2-z PMID: 10797316.
16. Nishida K, Mine S, Utsunomiya T, Inoue H, Okamoto M, Udagawa H, et al. Global analysis of altered gene expressions during the process of esophageal squamous cell carcinogenesis in the rat: a study combined with a laser microdissection and a cDNA microarray. Cancer research. 2005; 65(2):401-9. Epub 2005/02/08. PMID: 15695380.
17. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics (Oxford, England). 2004; 5(4):557-72. Epub 2004/10/12. doi: 10.1093/biostatistics/kxh008 PMID: 15475419.
18. Venkatraman ES, Olshen AB. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics (Oxford, England). 2007; 23(6):657-63. Epub 2007/01/20. doi: 10.1093/bioinformatics/btl646 PMID: 17234643.
19. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(50):20007-12. Epub 2007/12/14. doi: 10.1073/pnas.0710052104 PMID: 18077431; PubMed Central PMCID: PMCPmc2148413.
20. Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome biology. 2011; 12(4):R41. Epub 2011/04/30. doi: 10.1186/gb-2011-12-4-r41 PMID: 21527027; PubMed Central PMCID: PMCPmc3218867.
21. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, et al, SOX2 is an amplified lineagesurvival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 2009; 41(11):1238-42 Epub 2009/10/06. doi: 10.1038/ng.465 PMID: 19801978; PubMed Central PMCID: PMCPmc2783775.
22. Schafer M, Schwender H, Merk S, Haferlach C, Ickstadt K, Dugas M. Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities. Bioinformatics (Oxford, England). 2009; 25(24):3228-35. Epub 2009/10/16. doi: 10.1093/bioinformatics/btp592 PMID: 19828576.
23. Cheung HW, Cowley GS, Weir BA, Boehm JS, Rusin S, Scott JA, et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108 (30):12372-7. Epub 2011/07/13. doi: 10.1073/pnas.1109363108 PMID: 21746896; PubMed Central PMCID: PMCPmc3145679.
24. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell. 2003; 114(3):323-34. Epub 2003/08/14. PMID: 12914697.
25. Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS. A census of amplified and overexpressed human cancer genes. Nat Rev Cancer. 2010; 10(1):59-64. Epub 2009/12/24. doi: 10.1038/nrc2771 PMID: 20029424.
26. Song Y, Li L, Ou Y, Gao Z, Li E, Li X, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014; 509(7498):91-5. Epub 2014/03/29. doi: 10.1038/nature13176 PMID: 24670651.
27. Lin DC, Hao JJ, Nagata Y, Xu L, Shang L, Meng X, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet. 2014; 46(5):467-73. Epub 2014/04/02. doi:10. 1038/ng.2935 PMID: 24686850; PubMed Central PMCID: PMCPmc4070589.
28. Bandla S, Pennathur A, Luketich JD, Beer DG, Lin L, Bass AJ, et al. Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma. The Annals of thoracic surgery. 2012; 93 (4):1101-6. Epub 2012/03/28. doi: 10.1016/j.athoracsur.2012.01.064 PMID: 22450065; PubMed Central PMCID: PMCPmc3401935.
29. Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, et al. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer research. 2003; 63(13):3724-8. Epub 2003/07/04. PMID: 12839965.
30. Miyawaki Y, Kawachi H, Ooi A, Eishi Y, Kawano T, Inazawa J, et al. Genomic copy-number alterations of MYC and FHIT genes are associated with survival in esophageal squamous-cell carcinoma. Cancer science. 2012; 103(8):1558-66. Epub 2012/05/15. doi: 10.1111/j.1349-7006.2012.02329.x PMID: 22578181.
31. Feng J, Zhang X, Zhu H, Wang X, Ni S, Huang J. High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer. American journal of clinical pathology. 2012; 138 (2):230-5. Epub 2012/08/21. doi: 10.1309/ajcpdhqfnyjz01yg PMID: 22904134.
32. Robbs BK, Cruz AL, Werneck MB, Mognol GP, Viola JP. Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Molecular and cellular biology. 2008; 28(23):7168-81. Epub 2008/09/24. doi: 10.1128/mcb.00256-08 PMID: 18809576; PubMed Central PMCID: PMCPmc2593389.
33. Mimura K, Kono K, Hanawa M, Mitsui F, Sugai H, Miyagawa N, et al. Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma. British journal of cancer. 2005; 92(7):1253-60. Epub 2005/03/24. doi: 10.1038/sj.bjc.6602499 PMID: 15785739; PubMed Central PMCID: PMCPmc2361961.
34. Huang JX, Zhao K, Lin M, Wang Q, Xiao W, Lin MS, et al. HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma. Oncology letters. 2013; 6(1):13-8. Epub 2013/08/16. doi: 10.3892/ol.2013.1348 PMID: 23946770; PubMed Central PMCID: PMCPmc3742794.
35. Kato H, Arao T, Matsumoto K, Fujita Y, Kimura H, Hayashi H, et al. Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma. International journal of oncology. 2013; 42 (4):1151-8. Epub 2013/02/22. doi: 10.3892/ijo.2013.1830 PMID: 23426935; PubMed Central PMCID: PMCPmc3622677.
36. Zhan N, Dong WG, Tang YF, Wang ZS, Xiong CL. Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma. Medical oncology (Northwood, London, England). 2012; 29(2):933-40. Epub 2011/02/15. doi: 10.1007/s12032-011-9850-y PMID: 21318736.
37. Wu X, Zhang J, Zhen R, Lv J, Zheng L, Su X, et al. Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models. Journal of translational medicine. 2012; 10:180. Epub 2012/09/01. doi: 10.1186/1479-5876-10-180 PMID: 22935382; PubMed Central PMCID: PMCPmc3485623.
38. Daly RJ. The Grb7 family of signalling proteins. Cell Signal. 1998; 10(9):613-8. Epub 1998/10/30. PMID: 9794242.
39. Yokote K, Margolis B, Heldin CH, Claesson-Welsh L. Grb7 is a downstream signaling component of platelet-derived growth factor alpha-and beta-receptors. The Journal of biological chemistry. 1996; 271 (48):30942-9. Epub 1996/11/29. PMID: 8940081.
40. Han DC, Shen TL, Guan JL. The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene. 2001; 20(44):6315-21. Epub 2001/10/19. doi:10. 1038/sj.onc.1204775 PMID: 11607834.
41. Han DC, Shen TL, Miao H, Wang B, Guan JL. EphB1 associates with Grb7 and regulates cell migration. The Journal of biological chemistry. 2002; 277(47):45655-61. Epub 2002/09/12. doi: 10.1074/jbc. M203165200 PMID: 12223469.
42. Shen TL, Han DC, Guan JL. Association of Grb7 with phosphoinositides and its role in the regulation of cell migration. The Journal of biological chemistry. 2002; 277(32):29069-77. Epub 2002/05/22. doi:10. 1074/jbc.M203085200 PMID: 12021278.
43. Li H, Sanchez-Torres J, del Carpio AF, Nogales-Gonzalez A, Molina-Ortiz P, Moreno MJ, et al. The adaptor Grb7 is a novel calmodulin-binding protein: functional implications of the interaction of calmodulin with Grb7. Oncogene. 2005; 24(26):4206-19. Epub 2005/04/05. doi: 10.1038/sj.onc.1208591 PMID: 15806159.
44. Pradip D, Bouzyk M, Dey N, Leyland-Jones B. Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules. American journal of cancer research. 2013; 3(2):173-95. Epub 2013/04/18. PMID: 23593540; PubMed Central PMCID: PMCPmc3623837.
45. Chu PY, Li TK, Ding ST, Lai IR, Shen TL. EGF-induced Grb7 recruits and promotes Ras activity essential for the tumorigenicity of Sk-Br3 breast cancer cells. The Journal of biological chemistry. 2010; 285 (38):29279-85. Epub 2010/07/14. doi: 10.1074/jbc.C110.114124 PMID: 20622016; PubMed Central PMCID: PMCPmc2937960.
46. Zhang D, Shao C, Hu S, Ma S, Gao Y. Novel nonphosphorylated peptides with conserved sequences selectively bind to Grb7 SH2 domain with affinity comparable to its phosphorylated ligand. PLoS One. 2012; 7(1):e29902. Epub 2012/01/19. doi: 10.1371/journal.pone.0029902 PMID: 22253820; PubMed Central PMCID: PMCPmc3256188.
47. Ambaye ND, Pero SC, Gunzburg MJ, Yap M, Clayton DJ, Del Borgo MP, et al. Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer progression. Journal of molecular biology. 2011; 412(3):397-411. Epub 2011/08/02. doi: 10.1016/j.jmb.2011.07.030 PMID: 21802427.
48. Ambaye ND, Gunzburg MJ, Lim RC, Price JT, Wilce MC, Wilce JA. Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists. Bioorganic & medicinal chemistry. 2011; 19(1):693-701. Epub 2010/12/08. doi: 10.1016/j.bmc.2010.10.030 PMID: 21134757.
49. Porter CJ, Matthews JM, Mackay JP, Pursglove SE, Schmidberger JW, Leedman PJ, et al. Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation. BMC structural biology. 2007; 7:58. Epub 2007/09/27. doi: 10.1186/1472-6807-7-58 PMID: 17894853; PubMed Central PMCID: PMCPmc2131756.
50. Justilien V, Walsh MP, Ali SA, Thompson EA, Murray NR, Fields AP. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. Cancer cell. 2014; 25(2):139-51. Epub 2014/02/15. doi: 10.1016/j.ccr.2014.01.008 PMID: 24525231; PubMed Central PMCID: PMCPmc3949484.
51. Sahlberg KK, Hongisto V, Edgren H, Makela R, Hellstrom K, Due EU, et al. The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells. Molecular oncology. 2013; 7(3):392-401. Epub 2012/12/21. doi: 10.1016/j.molonc.2012.10.012 PMID: 23253899.